Pancreatic Cancer Research

ResearcherUniversity of LouisvilleNo recent work listed

Robert A Mitchell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8852-839X; OpenAlex author ID A5003848548; NIH RePORTER profile ID 7360475. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
1
Labs led
1
Collaborators
7
Papers, trials and grants by year

2013: 1 grant · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 2

  1. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2022-006221↗
  2. The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression. Co-author DOI 10.1038/s41467-022-28407-4↗

Grants 1

  1. Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization R01CA129967↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew R. Woeste · 2 shared papers, 2022–2023 · strength 0.28
  2. Chuanlin Ding · 2 shared papers, 2022–2023 · strength 0.28
  3. Anne E. Geller · 2 shared papers, 2022–2023 · strength 0.28
  4. Jun Yan · 2 shared papers, 2022–2023 · strength 0.28
  5. Robert C.G. Martin · 2 shared papers, 2022–2023 · strength 0.28
  6. Yan Li · 1 shared paper, 2023 · strength 0.15
  7. Haixun Guo · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.